Literature DB >> 18765913

Crystallographic study of G178S mutant of human proliferating cell nuclear antigen.

Asami Hishiki1, Toshiyuki Shimizu, Aya Serizawa, Haruo Ohmori, Mamoru Sato, Hiroshi Hashimoto.   

Abstract

Proliferating cell nuclear antigen (PCNA) is an evolutionarily conserved protein that forms a ring-shaped homotrimer that functions as a sliding clamp for DNA replication. The rev6-1 mutation of Saccharomyces cerevisiae, which inactivates both translesion DNA synthesis and damage-avoidance pathways while having little effect on normal cell growth, has a G178S substitution in the PCNA protein. Human PCNA protein carrying the G178S substitution was crystallized. Two crystal forms were obtained under similar conditions. Crystal forms I and II belong to space groups P2(1), with unit-cell parameters a = 84.1, b = 130.2, c = 97.8 A, beta = 113.4 degrees , and P2(1)2(1)2(1), with unit-cell parameters a = 68.1, b = 100.2, c = 131.2 A, respectively. Structural analyses by molecular replacement are now in progress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765913      PMCID: PMC2531271          DOI: 10.1107/S174430910802277X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  15 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

Authors:  Carsten Hoege; Boris Pfander; George-Lucian Moldovan; George Pyrowolakis; Stefan Jentsch
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

Review 3.  PCNA, the maestro of the replication fork.

Authors:  George-Lucian Moldovan; Boris Pfander; Stefan Jentsch
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  The Saccharomyces cerevisiae rev6-1 mutation, which inhibits both the lesion bypass and the recombination mode of DNA damage tolerance, is an allele of POL30, encoding proliferating cell nuclear antigen.

Authors:  Hengshan Zhang; Peter E M Gibbs; Christopher W Lawrence
Journal:  Genetics       Date:  2006-06-18       Impact factor: 4.562

6.  Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design.

Authors:  George Kontopidis; Su-Ying Wu; Daniella I Zheleva; Paul Taylor; Campbell McInnes; David P Lane; Peter M Fischer; Malcolm D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-28       Impact factor: 11.205

7.  A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.

Authors:  D I Zheleva; N Z Zhelev; P M Fischer; S V Duff; E Warbrick; D G Blake; D P Lane
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

8.  Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1.

Authors:  John B Bruning; Yousif Shamoo
Journal:  Structure       Date:  2004-12       Impact factor: 5.006

9.  Preparation and crystallization of human flap endonuclease FEN-1 in complex with proliferating-cell nuclear antigen, PCNA.

Authors:  Shigeru Sakurai; Ken Kitano; Kengo Okada; Keisuke Hamada; Hiroshi Morioka; Toshio Hakoshima
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-04-25

10.  Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation.

Authors:  Philipp Stelter; Helle D Ulrich
Journal:  Nature       Date:  2003-09-11       Impact factor: 49.962

View more
  4 in total

1.  Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication.

Authors:  Chandanamali Punchihewa; Akira Inoue; Asami Hishiki; Yoshihiro Fujikawa; Michele Connelly; Benjamin Evison; Youming Shao; Richard Heath; Isao Kuraoka; Patrick Rodrigues; Hiroshi Hashimoto; Masanobu Kawanishi; Mamoru Sato; Takashi Yagi; Naoaki Fujii
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

2.  Structural basis for novel interactions between human translesion synthesis polymerases and proliferating cell nuclear antigen.

Authors:  Asami Hishiki; Hiroshi Hashimoto; Tomo Hanafusa; Keijiro Kamei; Eiji Ohashi; Toshiyuki Shimizu; Haruo Ohmori; Mamoru Sato
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

3.  Initial crystallographic study of human PCNA in complex with a peptide containing the noncanonical PIP-box sequence of human DNA polymerase iota.

Authors:  Asami Hishiki; Toshiyuki Shimizu; Tomo Hanafusa; Haruo Ohmori; Mamoru Sato; Hiroshi Hashimoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-09-30

4.  The transcription factor TFII-I promotes DNA translesion synthesis and genomic stability.

Authors:  Farjana J Fattah; Kodai Hara; Kazi R Fattah; Chenyi Yang; Nan Wu; Ross Warrington; David J Chen; Pengbo Zhou; David A Boothman; Hongtao Yu
Journal:  PLoS Genet       Date:  2014-06-12       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.